Pharmaceutical products

Contract Value:: -
Notice Type:: Contract Notice

Published Date:: 29 October 2019
Closing Date:: 25 November 2019

Location(s):: ES21 País Vasco (ES Spain/ESPAÑA)

Description:

Supply of the drugs Furosemide (DOE), Risperidone (DOE), Midazolam (DOE) and Rocuronium (DOE)

With this contracting file whose conditions are established in the specifications, it is intended to cover the use of the medicine included in the file to meet the clinical needs of Osakidetza patients and related centers and which are summarized in the report's memory.

Furosemide (DOE) 20 mg ampoules

Active substance: Furosemide (DOE)

Amount of active substance: 20 mg

Pharmaceutical form: blister

Packaging conditions: unit dose

Maximum unit price: 1.15 EUR / 10 ampoules of 20 mg (Taxes not included)

Number of units planned: 500,000 ampoules of 20 mg (First year of contract)

Maximum estimated budget: 57,500.00 EUR (First year of contract)

Risperidone (DOE) oral 2 mg orodispersible tablets

Active substance: RISPERIDONA

Amount of active substance: 2 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose preferably

Maximum unit price: 0.04 euros / 2 mg tablet

(Taxes not included)

N or of planned units: 25,000 2 mg tablets

(First year of contract)

Maximum estimated budget: 1,000.00 euros

(First year of contract)

Risperidone (DOE) oral non-orodispersible tablets of 4 mg conditioned in stamped blister in which each tablet is properly identified

Active substance: RISPERIDONA

Amount of active substance: 4 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose (see section 5 "supply conditions")

Maximum unit price: 0.08 euros / 4 mg tablet

(Taxes not included)

N or of planned units: 15,000 4 mg tablets

(First year of contract)

Maximum estimated budget: 1,200.00 euros

(First year of contract)

Risperidone (DOE) oral non-orodispersible tablets of 6 mg conditioned in stamped blister in which each tablet is properly identified

Active substance: RISPERIDONA

Amount of active substance: 6 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose (see section 5 "supply conditions")

Maximum unit price: 0.09 euros / 6 mg tablet

(Taxes not included)

N or of planned units: 10,000 tablets of 6 mg

(First year of contract)

Maximum estimated budget: 900.00 euros

(First year of contract)

Risperidone (DOE) oral 6 mg orodispersible tablets

Active substance: RISPERIDONA

Amount of active substance: 6 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose preferably

Maximum unit price: 0.09 euros / 6 mg tablet

(Taxes not included)

N or of planned units: 10,000 tablets of 6 mg

(First year of contract)

Maximum estimated budget: 900.00 euros

(First year of contract)

Risperidone (DOE) oral orodispersible tablets

Active substance: RISPERIDONA

Amount of active substance: 0.5 mg, 1 mg, 2 mg

Pharmaceutical Form: orodispersible tablets

Packaging conditions: unit dose

Maximum unit price: 0.03 euros / 0.5 mg orodispersible tablet, 0.06 euros / 1 mg orodispersible tablet, 0.12 euros / 2 mg orodispersible tablet

(Taxes not included)

N or of planned units: 25,000 euros / 0.5 mg orodispersible tablet, 25,000 euros / 1 mg orodispersible tablet and 25,000 euros / 2 mg orodispersible tablet

(First year of contract)

Maximum estimated budget: 5,250.00 euros

(First year of contract)

Risperidone (DOE) oral solution

Active substance: RISPERIDONA

Amount of active substance: 1 mg / ml

Pharmaceutical Form: solution

Packaging conditions: unit dose

Maximum unit price: 0.67 euros / 30 ml container of 1 mg / ml oral solution and 2.22 euros / 100 ml container of 1 mg / ml solution

(Taxes not included)

N or of planned units: 1,200 containers of 30 ml of oral solution of 1 mg / ml and 800 containers of 100 ml of oral solution of 1 mg / ml

(First year of contract)

Maximum estimated budget: 2,580.00 euros

(First year of contract)

Parenteral Midazolam (DOE) in bottle

Active ingredient: MIDAZOLAM

Amount of active substance: 1 mg / ml, 100 ml

Pharmaceutical Form: bottle

Packaging conditions: unit dose preferably

Maximum unit price: 3.50 euros / 100 ml container

(Taxes not included)

N or of planned units: 2,000 containers

(First year of contract)

Maximum estimated budget: 7,000.00 euros

(First year of contract)

Rocuronium (DOE) plastic blister

Active ingredient: ROCURONY

Amount of active substance: 10 mg / ml, 5 ml

Pharmaceutical Form: plastic vial

Packaging conditions: unit dose

Maximum unit price: 1.95 euros / blister

(Taxes not included)

N or of planned units: 92,000 ampoules

(First year of contract)

Maximum estimated budget: 179,400.00 euros

(First year of contract)

Furosemide (DOE) 250 mg ampoules or vials

Active substance: FUROSEMIDA (DOE)

Amount of active substance: 250 mg

Pharmaceutical form: vial or vial

Packaging conditions: unit dose

Maximum unit price: 0.63 euros / vial or 250 mg vial

(Taxes not included)

N or of planned units: 30,000 ampoules or vials

(First year of contract)

Maximum estimated budget: 18,900.00 euros

(First year of contract)

Furosemide (DOE) tablets

Active substance: FUROSEMIDA (DOE)

Amount of active substance: 40 mg

Pharmaceutical Form: tablets

Packaging conditions: mandatory unit dose (see point 5 of "supply conditions")

Maximum unit price: 24.06 euros / 1,000 tablets

(Taxes not included)

N or of planned units: 300,000 tablets

(First year of contract)

Maximum estimated budget: 7,218.00 euros

(First year of contract)

Parenteral Risperidone (DOE)

Active substance: RISPERIDONA

Amount of active substance: 25 mg, 37.5 mg and 50 mg

Pharmaceutical form: syringe

Packaging conditions: unit dose

Maximum unit price: 78.43 euros / 25 mg syringe, 101.95 euros / 37.5 mg syringe, 125.49 euros / 50 mg syringe

(Taxes not included)

N or of planned units: 150 syringes of 25 mg, 200 syringes of 37.5 mg and 400 syringes of 50 mg

(First year of contract)

Maximum estimated budget: 82,350.50 euros

(First year of contract)

Risperidone (DOE) oral 0.5 mg non-orodispersible tablets conditioned in stamped blister in which each tablet is properly identified

Active substance: RISPERIDONA

Amount of active substance: 0.5 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose (see point 5 of “supply conditions”)

Maximum unit price: 0.02 euros / tablet

(Taxes not included)

N or of planned units: 25,000 tablets

(First year of contract)

Maximum estimated budget: 500.00 euros

(First year of contract)

Risperidone (DOE) oral 0.5 mg non-orodispersible tablets

Active substance: RISPERIDONA

Amount of active substance: 0.5 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose preferably

Maximum unit price: 0.02 euros / tablet

(Taxes not included)

N or of planned units: 25,000 tablets

(First year of contract)

Maximum estimated budget: 500.00 euros

(First year of contract)

Risperidone (DOE) oral non-orodispersible tablets of 1 mg and 3 mg conditioned in stamped blister in which each tablet is properly identified

Active substance: RISPERIDONA

Amount of active substance: 1 mg and 3 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose (see point 5 of “supply conditions”)

Maximum unit price: 0.03 euros / 1 mg tablet and 0.05 euros / 3 mg tablet

(Taxes not included)

N or of planned units: 25,000 tablets of 1 mg and 25,000 tablets of 3 mg

(First year of contract)

Maximum estimated budget: 2,000.00 euros

(First year of contract)

Risperidone (DOE) oral non-orodispersible tablets of 1 mg and 3 mg

Active substance: RISPERIDONA

Amount of active substance: 1 mg and 3 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose preferably

Maximum unit price: 0.03 euros / 1 mg tablet and 0.05 euros / 3 mg tablet

(Taxes not included)

N or of planned units: 25,000 tablets of 1 mg and 25,000 tablets of 3 mg

(First year of contract)

Maximum estimated budget: 2,000.00 euros

(First year of contract)

Risperidone (DOE) oral non-orodispersible tablets of 2 mg conditioned in stamped blister in which each tablet is properly identified

Active substance: RISPERIDONA

Amount of active substance: 2 mg

Pharmaceutical Form: tablets

Packaging conditions: unit dose (see point 5 of “supply conditions”)

Maximum unit price: 0.04 euros / 2 mg tablet

(Taxes not included)

N or of planned units: 25,000 2 mg tablets

(First year of contract)

Maximum estimated budget: 1,000.00 euros

(First year of contract)

: Download full details as .pdf

The Buyer:: Dirección General — Osakidetza-Servicio Vasco de Salud

CPV Code(s):: 33600000 - Pharmaceutical products